The operation also is aimed at transforming Bristol-Myers Squibb ( BMS ) " into a next-generation BioPharma company that pairs the scale and resources of a mid-sized pharmaceutical company with the entrepreneurial spirit and innovative focus of a biotech startup , " it said .